Successful introgression of wMel Wolbachia into Aedes aegypti populations in Fiji, Vanuatu and Kiribati.
Cameron Paul SimmonsWesley DonaldLekon TagaviLen TarivondaTimothy QuaiRaynelyn TavoaTebikau NoranErirau ManikaotiLavinia KareauaTabomoa Tinte AbwaiDip ChandVineshwaran RamaVimal DeoKharishma Karti DeoAminiasi TavuiiWame ValentineRaviikash PrasadEremasi SeruLeikitah NaitukuAnaseini RatuMark HeskethNichola KennySarah C BeebeAnjali A GoundarAndrew McCawMolly BuntineBen GreenTibor FrossardJeremie R L GillesD Albert JoubertGeoff WilsonLe Quyen DuongJean B BouvierDarren StanfordCarolyn ForderJohanna M DuyvestynEtiene C PacidônioHeather A FloresNatalie WittmeierKate RetzkiPeter A RyanJai Andrew DentonRuth SmithymanStephanie K TanamasPeter KyrylosYi DongAnam KhalidLauren HodgsonKatherine L AndersScott L O'NeillPublished in: PLoS neglected tropical diseases (2024)
Pacific Island countries have experienced periodic dengue, chikungunya and Zika outbreaks for decades. The prevention and control of these mosquito-borne diseases rely heavily on control of Aedes aegypti mosquitoes, which in most settings are the primary vector. Introgression of the intracellular bacterium Wolbachia pipientis (wMel strain) into Ae. aegypti populations reduces their vector competence and consequently lowers dengue incidence in the human population. Here we describe successful area-wide deployments of wMel-infected Ae. aegypti in Suva, Lautoka, Nadi (Fiji), Port Vila (Vanuatu) and South Tarawa (Kiribati). With community support, weekly releases of wMel-infected Ae. aegypti mosquitoes for between 2 to 5 months resulted in wMel introgression in nearly all locations. Long term monitoring confirmed a high, self-sustaining prevalence of wMel infecting mosquitoes in almost all deployment areas. Measurement of public health outcomes were disrupted by the Covid19 pandemic but are expected to emerge in the coming years.